These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2454355)

  • 21. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O; Ertem B; Altun A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F; Ciriello G
    Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.
    Takeda T; Kohno M; Ishii M; Kubo S; Saruta T; Mizuno Y; Fukiyama K; Fujishima M; Yoshimura M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S158-63. PubMed ID: 1974508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R; Widmann L; Uberbacher HJ; Hörrmann M; Machwirth M; Stienen U
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S; Masumura H; Kaifu Y; Yuasa S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of carvedilol in older and younger patients.
    Morgan T; Anderson A; Cripps J; Adam W
    J Hum Hypertens; 1990 Dec; 4(6):709-15. PubMed ID: 2096213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L; van der Does R; Hörrmann M; Machwirth M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
    Tanaka M; Masumura H; Tanaka S; Akashi A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
    Kim EJ; Song WH; Lee JU; Shin MS; Lee S; Kim BO; Hong KS; Han SW; Park CG; Seo HS
    Hypertens Res; 2014 Jan; 37(1):50-6. PubMed ID: 24026037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.
    Radevski IV; Valtchanova SP; Candy GP; Tshele EF; Sareli P
    Am J Cardiol; 1999 Jul; 84(1):70-5. PubMed ID: 10404854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol and atenolol once daily in the treatment of hypertension.
    Luurila OJ; Härkönen R; Hilden M; Icen R; Kohvakka A; Linna M; Sillanpää J; Vänskä O; Lukkala K
    J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of manidipine on circadian blood pressure in essential hypertension.
    Nakamura T; Honma H; Kohno I; Tsuruta I; Ishii H; Tamura K
    Blood Press Suppl; 1992; 3():94-101. PubMed ID: 1343299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.
    Rittinghausen R
    Drugs; 1988; 36 Suppl 6():92-101. PubMed ID: 2908307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T; Snowden R; Butcher L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.